EnSoTrol

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEnSoTrol
Drug Alias Nameglipizide EnSoTrol (Shire)nifedipine EnSoTrol (Shire)glipizide SRnifedipine SR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsDiabetes Mellitus, Type 2Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSupernus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSupernus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Hypertension

Other Information

ATC CodeN/A
Related LinksN/A